Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.32213 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.26795 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.26816 | 52 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.18845 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.18124 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.37906 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.33615 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.23469 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.20463 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.2302 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.25689 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.21623 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.26355 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.25805 | 52 |